Cargando…

Rifamycin SV-MMX® as the recommended self-treatment for moderate to severe travellers’ diarrhoea: reply

Detalles Bibliográficos
Autores principales:	Steffen, Robert, DuPont, Herbert L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509471/ https://www.ncbi.nlm.nih.gov/pubmed/30848824 http://dx.doi.org/10.1093/jtm/taz014

Ejemplares similares

Rifamycin SV-MMX(®) for treatment of travellers’ diarrhea: equally effective as ciprofloxacin and not associated with the acquisition of multi-drug resistant bacteria
por: Steffen, Robert, et al.
Publicado: (2018)

Development of a new travellers’ diarrhoea clinical severity classification and its utility in confirming rifamycin-SV efficacy
por: DuPont, Herbert L, et al.
Publicado: (2023)

Pharmacokinetics and Safety of Rifamycin SV after Single and Multiple Doses of MMX(®) Modified Release Tablets in Healthy Male and Female Volunteers
por: Di Stefano, Andrea Francesco Daniele, et al.
Publicado: (2021)

Once-daily MMX mesalamine for the treatment of mild-to-moderate ulcerative colitis
por: Kedia, Prashant, et al.
Publicado: (2007)

Air Travel and the Spread of Influenza: Authors' Reply
por: Brownstein, John S, et al.
Publicado: (2006)

Addendum needed on COVID-19 travel study – Authors' reply
por: Kiang, Mathew V, et al.
Publicado: (2021)

Estimating the incidence of norovirus acute gastroenteritis among US and European international travelers to areas of moderate to high risk of traveler’s diarrhea: a prospective cohort study protocol
por: Lindsay, Lisa, et al.
Publicado: (2018)

MMX(®) technology and its applications in gastrointestinal diseases
por: Nardelli, Silvia, et al.
Publicado: (2017)

The Ansamycin Antibiotic, Rifamycin SV, Inhibits BCL6 Transcriptional Repression and Forms a Complex with the BCL6-BTB/POZ Domain
por: Evans, Sian E., et al.
Publicado: (2014)

Budesonide MMX for the Induction of Remission of Mild to Moderate Ulcerative Colitis: A Pooled Safety Analysis
por: Lichtenstein, Gary R., et al.
Publicado: (2015)

Infantile Diarrhœa
por: Khan, M. Maswood
Publicado: (1947)

Hill Diarrhœa
por: Crozier, G. G.
Publicado: (1906)

Quinoidine and Diarrhœa
por: McElderry, S. L.
Publicado: (1916)

Cocaine in Diarrhoea
por: Fuld, E.
Publicado: (1913)

Characterization of the Rifamycin-Degrading Monooxygenase From Rifamycin Producers Implicating Its Involvement in Saliniketal Biosynthesis
por: Zheng, Xiao-Fu, et al.
Publicado: (2020)

The role of rifaximin in the treatment and chemoprophylaxis of travelers’ diarrhea
por: Koo, Hoonmo L, et al.
Publicado: (2009)

Treatment of Chronic Diarrhœa
por: Mandkani, K. J.
Publicado: (1936)

Emetine and Tropical Diarrhœa
por: Valentine, J. A.
Publicado: (1912)

The Etiology of Hill Diarrhœa
por: Williams, C. L
Publicado: (1906)

Azithromycin for mild-to-moderate COVID-19 – Authors' reply
por: Hinks, Timothy S C
Publicado: (2021)

Deciphering the late steps of rifamycin biosynthesis
por: Qi, Feifei, et al.
Publicado: (2018)

Diarrhœa in the Breast-Fed Infant
por: Green-Armytage, V. B.
Publicado: (1925)

Tincture of Iodine in Dysentery and Diarrhœa
por: Shah, P. N.
Publicado: (1925)

Reply to 'No substantial long-term bias in the Cenozoic benthic foraminifera oxygen-isotope record'
por: Bernard, S., et al.
Publicado: (2018)

Burden of community diarrhoea in developing countries
por: Baker, Tess
Publicado: (2015)

Some Observations on Dysentery and Diarrhœa at Darjeeling
por: Ray, Nishi Kanta
Publicado: (1935)

Study on Dissolution Thermodynamics and Cooling Crystallization of Rifamycin S
por: Chen, Kui, et al.
Publicado: (2021)

Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study
por: Travis, Simon P L, et al.
Publicado: (2014)

Head and neck surgery recommendations during the COVID-19 pandemic – Author's reply
por: Mehanna, Hisham
Publicado: (2020)

Material designs and new physical properties in MX- and MMX-chain compounds
por: Yamashita, Masahiro, et al.
Publicado: (2014)

Budesonide MMX in the Treatment of Ulcerative Colitis: Current Perspectives on Efficacy and Safety
por: Maconi, Giovanni, et al.
Publicado: (2021)

Reply to Hallifax et al.: From Recommendations to Implementation: Also a Multidisciplinary Matter
por: Desmettre, Thibaut, et al.
Publicado: (2023)

Chronic Diarrhœa Radically Cured by Emetine Hydrochlor
por: Gupta, Jai Jai Ram
Publicado: (1917)

Rifamycin O, An Alternative Anti-Mycobacterium abscessus Agent
por: Hanh, Bui Thi Bich, et al.
Publicado: (2020)

Generation of Tetracycline and Rifamycin Resistant Chlamydia Suis Recombinants
por: Marti, Hanna, et al.
Publicado: (2021)

Stability of Non-Ionic Surfactant Vesicles Loaded with Rifamycin S
por: Marchianò, Verdiana, et al.
Publicado: (2022)

Canine bufavirus in faeces and plasma of dogs with diarrhoea, China
por: Li, Jingjiao, et al.
Publicado: (2019)

Sentinel surveillance for travellers' diarrhoea in primary care
por: Northey, Gemma, et al.
Publicado: (2007)

Diarrhoea in a large prospective cohort of European travellers to resource-limited destinations
por: Pitzurra, Raffaela, et al.
Publicado: (2010)

Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX(®) mesalamine
por: Nanda, Kavinderjit, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gesp0rra58h5o5j2dvjjgc7mc4